Chandra Bhagat Pharma Ltd: Financial Statements & Historical Data

Chandra Bhagat Pharma Ltd: Earnings returned to a reported profit of ₹3.00 crore in the quarter ending Mar 2026, compared with zero net profit in Mar 2025. Sales rose 313.6% to ₹91 crore against Mar 2025. Operating margin rose from 0.0% to 2.2% (2.2 percentage points higher). For the full year ending Mar 2026, operating margin improved to 3.4%.

Calculated from the stored statements below · Reporting periods remain separate

COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 8 October 2026, 5:52 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price38.2₹ per share

Reported P/E9.45Times

Book value per share43.9₹ per share

Reported ROCE12.1 %Reported return

Stored market and accounting figures

Price record: 8 October 2026, 5:52 pm +05:30. Not a live quote.

Measure	Stored figure
Market Cap	28.8 Cr.
Current Price	38.2
High / Low	53.0/29.7
Stock P/E	9.45
Book Value	43.9
Dividend Yield	0.00 %
ROCE	12.1 %
ROE	9.67 %
Face Value	10.0

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Mar 2026

Earnings returned to a reported profit of ₹3.00 crore in the quarter ending Mar 2026, compared with zero net profit in Mar 2025. Sales rose 313.6% to ₹91 crore against Mar 2025. Operating margin rose from 0.0% to 2.2% (2.2 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods. Prior-year profit was zero or negative; a conventional percentage growth comparison would be misleading.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

Metric	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	22	48	43	51	44	75	119	102	65	22	26	91
Expenses	21	47	42	50	43	74	124	104	66	22	24	89
Operating Profit	2	2	2	1	1	2	-5	-2	-1	-0	2	2
OPM %	7%	3.4%	3.8%	2.1%	2.3%	2.4%	-4.2%	-2.0%	-1.8%	-1.2%	7%	2.4%
Other Income	0	0	0	1	1	0	7	4	3	2	0	3
Interest	2	2	1	2	1	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	1	1	0
Profit before tax	0	0	1	1	1	1	1	1	1	1	1	4
Tax %	25%	33%	24%	31%	31%	15%	32%	34%	-11%	69%	22%	26%
Net Profit	0	0	0	0	0	1	1	1	1	0	0	3
EPS in Rs	0.04	0.21	0.57	0.48	0.49	0.72	0.83	1.19	0.90	0.23	0.60	3.45

Last Updated: September 29, 2026, 7:51 am

EARNINGS

Annual performance

Mar 2026

Earnings grew faster than sales in the year ending Mar 2026. Sales rose 30.3% to ₹116 crore against Mar 2025. Net profit rose 200.0% to ₹3.00 crore against the same period a year earlier. Operating margin rose from 1.1% to 3.4% (2.3 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 5:48 am

Metric	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	61	80	90	97	106	94	71	94	120	221	89	116
Expenses	58	76	85	92	102	91	67	91	116	228	88	112
Operating Profit	3	3	4	5	5	3	4	3	3	-7	1	4
OPM %	4.9%	4.3%	4.9%	4.7%	4.3%	3.3%	5%	3.0%	2.8%	-3.2%	0.7%	3.3%
Other Income	0	0	0	1	0	0	0	2	0	11	3	3
Interest	2	3	4	4	4	3	4	3	2	1	2	2
Depreciation	0	0	0	0	0	0	0	0	0	1	1	1
Profit before tax	1	1	1	2	1	0	0	1	1	2	1	4
Tax %	39%	51%	27%	33%	22%	26%	32%	27%	22%	33%	26%	26%
Net Profit	0	0	1	1	1	0	0	1	1	2	1	3
EPS in Rs	10.29	8.37	15.79	24.64	10.29	0.41	0.25	1.06	1.21	2.03	1.14	4.04
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Year-on-year profit growth table

YoY Net Profit Growth

Year	2017-2018	2018-2019	2019-2020	2022-2023	2023-2024	2024-2025	2025-2026
YoY Net Profit Growth (%)	0.00%	0.00%	-100.00%	0.00%	100.00%	-50.00%	200.00%
Change in YoY Net Profit Growth (%)	0.00%	0.00%	-100.00%	100.00%	100.00%	-150.00%	250.00%

Growth

Compounded Sales Growth
10 Years:	4%
5 Years:	-2%
3 Years:	-3%
TTM:	-61%

Compounded Profit Growth
10 Years:	7%
5 Years:	23%
3 Years:	2%
TTM:	-44%

Stock Price CAGR
10 Years:	Not available
5 Years:	4%
3 Years:	-23%
1 Year:	-39%

Return on Equity
10 Years:	4%
5 Years:	3%
3 Years:	4%
Last Year:	3%

Last Updated: September 5, 2025, 2:51 pm

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹17 crore in Mar 2026. They decreased from ₹21 crore in Mar 2025 (19.0% lower). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: May 29, 2026, 3:30 am

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.42	0.42	0.42	0.42	0.67	8	8	8	8	8	8	8
Reserves	6	6	7	8	14	18	18	19	20	21	22	26
Borrowings	28	28	22	22	31	30	27	21	19	16	21	17
Other Liabilities	8	10	26	28	37	19	19	25	14	56	51	45
Total Liabilities	42	44	56	58	83	75	72	72	61	102	102	94
Fixed Assets	1	1	1	1	0	0	0	0	1	3	3	3
CWIP	0	0	0	0	0	0	0	0	0	0	0	0
Investments	0	0	5	1	4	1	0	0	0	0	0	2
Other Assets	41	44	51	56	78	74	71	72	60	99	99	90
Total Assets	42	44	56	58	83	75	72	72	61	102	102	94

CASH & FUNDING

Cash generation

Mar 2026

Operating activities generated ₹9.00 crore in Mar 2026. Reported free cash flow for the same period was ₹8.00 crore. Positive operating cash flow shows cash generated by operations in this period; examine its consistency and the capital expenditure needed to sustain the business. Operating cash flow was equivalent to 300.0% of the ₹3.00 crore reported annual profit for the same year ending Mar 2026, before capital expenditure.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

Month	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	0	0	-9	-6	4	-7	8	12	5	6	-6	9
Cash from Investing Activity +	0	0	0	-0	-0	0	0	0	-0	-2	-1	-0
Cash from Financing Activity +	0	0	8	7	-4	7	-6	-10	-4	-6	2	-6
Net Cash Flow	0	0	-1	-0	-0	-0	2	3	1	-1	-4	2
Free Cash Flow	0	0	-9	-6	4	-7	8	12	5	4	-6	8
CFO/OP	0%	0%	-200%	-129%	98%	-238%	229%	440%	164%	-94%	-805%	250%

Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
Period	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Free Cash Flow	0.00	0.00	-9.00	-6.00	4.00	-7.00	8.00	12.00	5.00	4.00	-6.00	8.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 115 in Mar 2025. That is 79 days higher than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

CAPITAL RETURNS

Returns on capital & equity

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	65.15	70.99	66.15	79.92	67.16	90.32	54.50	79.61	58.22	24.98	65.05	151.31
Inventory Days	161.44	176.71	122.83	132.66	144.60	173.53	186.75	214.70	153.25	99.59	15.23	3.44
Days Payable	53.01	43.18	32.81	80.69	68.58	117.37	53.13	78.51	11.98	10.62	23.21	44.58
Cash Conversion Cycle	173.59	204.52	156.17	131.89	143.18	146.48	188.12	215.80	199.49	113.95	57.06	110.17
Working Capital Days	148.78	166.47	133.63	124.96	138.50	83.39	147.60	177.18	103.94	75.00	35.89	115.28
ROCE %	11.68%	10.44%	10.40%	14.77%	17.42%	13.13%	6.97%	7.44%	8.62%	7.13%	7.95%	6.00%

SHAREHOLDERS

Ownership trends

Mar 2026

Promoters held 73.02% in Mar 2026. Their share was 1.82 percentage points higher than in Mar 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. FIIs held 0.00% in Mar 2026, 0.61 percentage points below their holding in Mar 2025. DIIs held 0.00% in Mar 2026, unchanged from their holding in Mar 2025.

Shareholding comparison

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

SHAREHOLDER PARTICIPATION

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

Month	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Promoters	70.42%	71.80%	71.80%	70.11%	69.09%	68.24%	68.69%	68.77%	69.29%	71.20%	72.19%	73.02%
FIIs	0.00%	0.00%	0.00%	0.00%	0.85%	0.85%	1.33%	1.33%	0.48%	0.61%	0.61%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.89%	0.89%	0.00%	0.00%	0.00%	0.00%
Public	29.58%	28.20%	28.20%	29.89%	30.07%	30.91%	29.09%	29.02%	30.23%	28.18%	27.20%	26.99%
No. of Shareholders	156	106	90	126	126	146	134	152	315	316	301	280

This stock is not held by any mutual fund.

ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	1.14	2.03	1.20	1.06	0.25
Diluted EPS (Rs.)	1.14	2.03	1.20	1.06	0.25
Cash EPS (Rs.)	2.40	2.88	1.55	1.22	0.29
Book Value[Excl.RevalReserv]/Share (Rs.)	39.72	38.45	36.42	35.35	34.30
Book Value[Incl.RevalReserv]/Share (Rs.)	39.72	38.45	36.42	35.35	34.30
Revenue From Operations / Share (Rs.)	114.93	293.40	158.61	124.68	93.70
PBDIT / Share (Rs.)	5.39	5.69	4.79	5.69	1.05
PBIT / Share (Rs.)	4.13	4.84	4.44	5.53	1.01
PBT / Share (Rs.)	1.54	3.00	1.54	1.45	0.36
Net Profit / Share (Rs.)	1.14	2.03	1.20	1.05	0.25
PBDIT Margin (%)	4.68	1.93	3.01	4.56	1.12
PBIT Margin (%)	3.58	1.64	2.79	4.43	1.07
PBT Margin (%)	1.34	1.02	0.97	1.16	0.39
Net Profit Margin (%)	0.98	0.69	0.75	0.84	0.26
Return on Networth / Equity (%)	2.86	5.27	3.29	2.98	0.73
Return on Capital Employeed (%)	9.64	11.86	9.95	12.12	1.95
Return On Assets (%)	0.84	1.50	1.49	1.09	0.26
Long Term Debt / Equity (X)	0.07	0.04	0.14	0.20	0.36
Total Debt / Equity (X)	0.69	0.56	0.68	0.74	0.96
Asset Turnover Ratio (%)	0.85	2.73	1.80	1.30	0.96
Current Ratio (X)	1.41	1.38	2.19	1.86	2.13
Quick Ratio (X)	1.40	1.26	1.11	0.96	1.06
Inventory Turnover Ratio (X)	18.51	1.54	0.53	0.07	0.23
Interest Coverage Ratio (X)	2.09	3.09	1.65	1.40	1.65
Interest Coverage Ratio (Post Tax) (X)	1.44	2.10	1.41	1.26	1.39
Enterprise Value (Cr.)	59.68	83.14	85.69	99.92	52.54
EV / Net Operating Revenue (X)	0.68	0.37	0.71	1.06	0.74
EV / EBITDA (X)	14.68	19.38	23.71	23.26	66.02
MarketCap / Net Operating Revenue (X)	0.45	0.32	0.61	0.91	0.42
Price / BV (X)	1.32	2.47	2.66	3.22	1.15
Price / Net Operating Revenue (X)	0.45	0.32	0.61	0.91	0.42
EarningsYield	0.02	0.02	0.01	0.01	0.01

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Chandra Bhagat Pharma Ltd	28.8 Cr.	38.2	53.0/29.7	9.45	43.9	0.00 %	12.1 %	9.67 %	10.0
Gujarat Terce Laboratories Ltd	27.6 Cr.	35.4	59.8/29.0	12.4	12.5	0.00 %	39.2 %	30.2 %	10.0
Bacil Pharma Ltd	33.0 Cr.	23.0	61.8/10.6	52.4	17.6	0.00 %	3.93 %	6.21 %	10.0
Murae Organisor Ltd	38.8 Cr.	0.19	0.44/0.19	2.56	1.02	0.00 %	4.20 %	5.69 %	1.00
Colinz Laboratories Ltd	18.5 Cr.	73.5	87.9/36.1	37.0	39.9	0.00 %	7.20 %	5.23 %	10.0
Industry Average	17,076.32 Cr	1,211.61		52.97	211.25	0.40%	26.15%	16.59%	6.06

All Competitor Stocks of Chandra Bhagat Pharma Ltd